Drug Shortage Report for TARO-CLARITHROMYCIN

Last updated on 2021-09-15 History
Report ID 132850
Drug Identification Number 02390442
Brand name TARO-CLARITHROMYCIN
Common or Proper name CLARITHROMYCIN
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN
Strength(s) 125MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 55
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-01
Estimated end date 2021-08-27
Actual end date 2021-09-09
Shortage status Resolved
Updated date 2021-09-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2021-09-15 French Compare
v17 2021-09-15 English Compare
v16 2021-08-24 French Compare
v15 2021-08-24 English Compare
v14 2021-08-20 French Compare
v13 2021-08-20 English Compare
v12 2021-08-04 French Compare
v11 2021-08-04 English Compare
v10 2021-08-04 French Compare
v9 2021-08-04 English Compare
v8 2021-07-13 French Compare
v7 2021-07-13 English Compare
v6 2021-06-16 French Compare
v5 2021-06-16 English Compare
v4 2021-05-01 French Compare
v3 2021-05-01 English Compare
v2 2021-01-31 French Compare
v1 2021-01-31 English Compare

Showing 1 to 18 of 18